Page last updated: 2024-10-17

coumarin and Atrial Fibrillation

coumarin has been researched along with Atrial Fibrillation in 17 studies

2H-chromen-2-one: coumarin derivative

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research Excerpts

ExcerptRelevanceReference
"To investigate the effectiveness of aspirin and coumarin in preventing thromboembolism in patients with non-rheumatic atrial fibrillation in general practice."9.09Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin. ( Hellemons, BS; Knottnerus, JA; Langenberg, M; Lemmens, T; Lodder, J; Schouten, HJ; van Ree, JW; Vermeer, F, 1999)
"A patient with mechanical heart valves developed bleeding, after the introduction of amiodarone and azithromycin."7.70Bleeding complication during coumarin therapy due to amiodarone and azithromycin. ( Bharat, V; Mohanty, B, 2000)
"To investigate the effectiveness of aspirin and coumarin in preventing thromboembolism in patients with non-rheumatic atrial fibrillation in general practice."5.09Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin. ( Hellemons, BS; Knottnerus, JA; Langenberg, M; Lemmens, T; Lodder, J; Schouten, HJ; van Ree, JW; Vermeer, F, 1999)
"The aim of the present study was to assess which clinical determinants influence coumarin and aspirin prescription in patients with atrial fibrillation in primary care."3.72Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment? ( Hak, E; Hoes, AW; Rutten, FH; Stalman, WA; Verheij, TJ, 2003)
" The major drawback of coumarin therapy is the increased risk of hemorrhage."3.72Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism. ( Rosendaal, FR; Torn, M; van der Meer, FJ, 2004)
"Anticoagulant treatment with coumarins is due to it unequivocal benefit and relatively low risk increasingly used for prevention of sudden cerebrovascular attacks, in atrial fibrillation, in the treatment of thromboembolic disease, as part of treatment after replacement of cardiac valves and other diseases."3.70[Retroperitoneal hematoma and femoral compression neuropathy--a complication of anticoagulation therapy after myocardial infarct]. ( Gonsorcík, J; Jonás, P; Jurgová, T; Kristian, P; Kucinský, R; Lazúr, J; Tokarcíková, A; Tomasch, J, 1998)
"A patient with mechanical heart valves developed bleeding, after the introduction of amiodarone and azithromycin."3.70Bleeding complication during coumarin therapy due to amiodarone and azithromycin. ( Bharat, V; Mohanty, B, 2000)

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (17.65)18.2507
2000's9 (52.94)29.6817
2010's5 (29.41)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schlieper, G1
Schwenger, V1
Remppis, A1
Keller, T1
Dechend, R1
Massberg, S1
Baldus, S1
Weinreich, T1
Hetzel, G1
Floege, J2
Mahfoud, F1
Fliser, D1
Schulman, S1
Krüger, T1
Hörl, WH1
Pabinger, I1
Tiede, A1
Kalina, U1
Knaub, S1
Germann, R1
Ostermann, H1
Lengyel, M2
Wijnen, PA1
Verschakelen, JA1
Bast, A1
Bekers, O1
Drent, M1
Rutten, FH1
Hak, E1
Stalman, WA1
Verheij, TJ1
Hoes, AW1
Geller, JC1
Torn, M1
van der Meer, FJ1
Rosendaal, FR1
Farsang, C1
Dénes, M1
Kiss, T1
Gandjour, J1
Zeindler, J1
Georgiadis, D1
Baumgartner, RW1
Schipper, JP1
Kristian, P1
Kucinský, R1
Gonsorcík, J1
Jonás, P1
Tokarcíková, A1
Lazúr, J1
Jurgová, T1
Tomasch, J1
Hellemons, BS1
Langenberg, M1
Lodder, J1
Vermeer, F1
Schouten, HJ1
Lemmens, T1
van Ree, JW1
Knottnerus, JA1
Hirsh, J1
Dalen, J1
Anderson, DR1
Poller, L1
Bussey, H1
Ansell, J1
Deykin, D1
Bharat, V1
Mohanty, B1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy and Tolerance of BERIPLEX® P/N in Subjects With Acquired Deficiency of Coagulation Factors II, VII, IX and X Due to Oral Anticoagulation[NCT00168077]Phase 340 participants Interventional2005-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for coumarin and Atrial Fibrillation

ArticleYear
[Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology].
    Der Internist, 2017, Volume: 58, Issue:5

    Topics: Anticoagulants; Atrial Fibrillation; Contraindications, Drug; Coumarins; Germany; Humans; Nephrology

2017
New anticoagulants in atrial fibrillation management.
    Thrombosis research, 2013, Volume: 131 Suppl 1

    Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-A

2013
[Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
    Praxis, 2005, Jan-26, Volume: 94, Issue:4

    Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrilla

2005
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.
    Chest, 2001, Volume: 119, Issue:1 Suppl

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Coumarins; Drug Interactions; Food; Heart

2001

Trials

2 trials available for coumarin and Atrial Fibrillation

ArticleYear
Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal.
    Annals of hematology, 2010, Volume: 89, Issue:3

    Topics: Aged; Anticoagulants; Antidotes; Atrial Fibrillation; Blood Coagulation Factors; Coumarins; Drug Com

2010
Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.
    BMJ (Clinical research ed.), 1999, Oct-09, Volume: 319, Issue:7215

    Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Female; Follow-Up Studies; Humans; Ma

1999

Other Studies

11 other studies available for coumarin and Atrial Fibrillation

ArticleYear
Coumarin use in dialysis patients with atrial fibrillation--more harm than benefit?
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:11

    Topics: Animals; Anticoagulants; Atrial Fibrillation; Calcinosis; Coumarins; Humans; Mice; Quality-Adjusted

2009
Coumarin use in dialysis patients with atrial [corrected] fibrillation: yes, after individual risk stratification.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:11

    Topics: Anticoagulants; Atrial Fibrillation; Coumarins; Humans; Kidney Failure, Chronic; Renal Dialysis; Str

2009
[Guiding principles for anticoagulant therapy in cardiology].
    Orvosi hetilap, 2010, Jun-06, Volume: 151, Issue:23

    Topics: Anticoagulants; Atrial Fibrillation; Cardiology; Cardiovascular Diseases; Coumarins; Heart Valve Pro

2010
Diffuse alveolar hemorrhage in coumarin users: a fibrosing interstitial pneumonia trigger?
    Lung, 2013, Volume: 191, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Coumarins; Female; Hemorrhage;

2013
Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?
    Family practice, 2003, Volume: 20, Issue:1

    Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Cross-Sectional Studies; Evidence-Bas

2003
[Atrial fibrillation as end point of hypertension. Can antihypertensive therapy prevent it?].
    MMW Fortschritte der Medizin, 2003, Nov-20, Volume: 145, Issue:47

    Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme

2003
Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism.
    Archives of internal medicine, 2004, Mar-22, Volume: 164, Issue:6

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Coumarins; Female; Heart Valve Prosthesis

2004
[Use of anticoagulant therapy in non-valvular atrial fibrillation. Analysis of a Hungarian cohort].
    Orvosi hetilap, 2004, Mar-07, Volume: 145, Issue:10

    Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Coumarins

2004
[Consensus on antithrombotic prophylaxis of vascular events in patients with manifested atherosclerotic vascular disease].
    Nederlands tijdschrift voor geneeskunde, 1998, Mar-28, Volume: 142, Issue:13

    Topics: Aged; Anticoagulants; Arteriosclerosis; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Cou

1998
[Retroperitoneal hematoma and femoral compression neuropathy--a complication of anticoagulation therapy after myocardial infarct].
    Vnitrni lekarstvi, 1998, Volume: 44, Issue:6

    Topics: Anticoagulants; Atrial Fibrillation; Cerebrovascular Disorders; Coumarins; Female; Hematoma; Hemorrh

1998
Bleeding complication during coumarin therapy due to amiodarone and azithromycin.
    The Journal of the Association of Physicians of India, 2000, Volume: 48, Issue:7

    Topics: Amiodarone; Anticoagulants; Atrial Fibrillation; Azithromycin; Coumarins; Drug Interactions; Fatal O

2000